Health Care
-
The future of vaccines: How an adjuvant is showing great promise
It’s a race to a moving finish line. People around the globe are lining up to get vaccinated as new variants of the coronavirus evolve and spread. Scientists continue their tireless work behind the scenes to find new vaccines and boosters to help avoid future infections from coronaviruses and other pathogens.
3M Corporate Research Materials Lab Scientists Mark Tomai, Ph.D. (immunologist), and George Griesgraber, Ph.D. (synthetic chemist), recently sat down with the American Chemical Society (ACS) to talk about a small molecule, or adjuvant, developed by their team at 3M. This 3M-052 adjuvant may help in the fight to vaccinate against SARS-CoV2 and other illnesses, including HIV.
- Listen to the ACS podcast“Solutions” – to hear additional details about how immune cells respond to vaccines, how adjuvants work and how they may help make vaccines more effective.
